Pay in 4 interest-free payments of $5.72 Learn more
.jpg)
Ships within 48 hours · Estimated delivery Aug 23 - Aug 28
Lets break down what it involves and how it can be tailored to your needs
What It Targets Our PT-141 peptide is designed to target: Hypoactive sexual desire disorder (HSDD) or chronically low libido that is distressing and not fully explained by pain, relationship conflict, or obvious hormonal deficits. Female sexual interest/arousal difficulties where desire and mental arousal are the main issues, even when lubrication or anatomy are otherwise normal. Men with low libido or mixed erectile challenges who have tried PDE5 inhibitors but still feel little desire or incomplete arousal. Couples who want a shared, timebound tool to reintroduce anticipation, spontaneity, and confidence as part of a broader intimacy reset
Working with a registered dietitian can help develop a personalised eating plan that meets nutritional needs whilst accommodating reduced appetite and any gastrointestinal symptoms
GLP-1R agonists effects on cardiovascular events The first pieces of evidence of the potential clinical benefit of GLP-1 agonists have emerged recently, pointing to a decrease of major adverse cardiovascular and cerebrovascular events (MACCE) including stroke, MI, cardiac mortality, acute coronary syndrome, and revascularization procedures
Two peptides, one protocol, targeting aging from inside and out
